Millions face debilitating hearing loss, tinnitus, and vertigo, but a medical breakthrough could soon offer true recovery. Trey speaks with ENT expert and CEO of Sound Pharmaceuticals, Dr. Jonathan Kil, to unpack the alarming connection between untreated hearing loss and dementia risk. Dr. Kil shares his personal experience with severe vertigo and details the 25-year journey behind SPI-1005, a landmark oral drug targeting Meniere's disease. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Trey Gowdy Podcast
Q & Trey: Proving Murder Without Evidence & Trial Failures in the Lindsay Clancy Case
Character Beyond the Scoreboard
Q & Trey: Are There Guardrails for Jury Confidentiality?
History Will Be Kinder to Kevin McCarthy
Get summaries like this every morning.
Free AI-powered recaps of The Trey Gowdy Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.